The QualityStocks Daily Stock List
- Better Choice Company, Inc. (BTTR)
- Concierge Technologies, Inc. (CNCG)
- Exactus, Inc. (EXDI)
- Gran Colombia Gold Corp. (TPRFF)
- HIVE Blockchain Technologies Ltd. (HVBTF)
- Jaguar Health, Inc. (JAGX)
- Williams Industrial Services Group Inc. (WLMS)
- Blue Eagle Lithium, Inc. (BEAG)
- INHIBITOR Therapeutics, Inc. (INTI)
- Bannerman Resources Limited (BNNLF)
- CleanSpark, Inc. (CLSK)
- AEON Global Health Corp. (AGHC)
- Anfield Energy, Inc. (ANLDF)
- KinerjaPay Corp. (KPAY)
Better Choice Company, Inc. (BTTR)
Market Wire News, Street Insider, All Cap Research, TeleTrader, Market Screener, Stockwatch, TradingView, Simply Wall St, Wallet Investor, and Investor Place reported previously on Better Choice Company, Inc. (BTTR), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Better Choice Company, Inc. is an animal health and wellness CBD (cannabidiol) company headquartered in New York, New York. It has acquired TruPet LLC and Bona Vida, Inc. Better Choice Company offers consumers a carefully curated collection of first-rate pet brands, hemp-derived CBD supplements, and other services that support pet wellness. The Company lists on the OTC Markets Group’s OTCQB.
Better Choice’s vision is to provide clean, holistic, and nutritional options for consumers who want to bring their own healthier lifestyle to their pets. The Company’s products promote wellness and support better and longer lives for pets.
Better Choice’s TruPet is an online seller of ultra-premium, all-natural pet food, treats and supplements. TruPet has a special concentration on freeze dried and dehydrated raw products. Bona Vida is an inventive emerging CBD platform. Bona Vida’s emphasis is on developing a portfolio of brand and product verticals within the animal and human health and wellness space.
Better Choice’s portfolio includes TruDog, an online seller of ultra-premium, freeze-dried raw pet food, treats and supplements, and Elvis Presley’s Hound Dog, a unique CBD platform. Furthermore, its portfolio includes TruGold, a hemp-based product line, and Rawgo!, a premium dehydrated dog food. Additionally, the Company’s portfolio includes Orapup, a dental health system for dogs, TruCat, a premium pet food and supplements brand for cats, and Pet Premium, a leading pet insurance provider.
Better Choice Company announced a strategic partnership in June of this year with Authentic Brands Group (ABG). ABG (New York City) is a global brand development, marketing, and entertainment company and owner of Elvis Presley Enterprises LLC. The strategic partnership is to launch an all-new line of CBD pet products under the Elvis Presley Hound Dog brand. ABG manages, elevates, and builds the long-term value of more than 50 consumer brands and properties via partnering with best-in-class manufacturers, wholesalers, and retailers.
In August, Better Choice Company and ABG announced the launch of a CBD pet product line under the Elvis Presley Hound Dog brand. The initial release comprised two SKUs (Stock Keeping Units), Hound Dog Peanut Butter Calming & Relaxation Support Supplement and Hound Dog Bacon Skin & Immune Support Supplement.
Today, Better Choice Company announced the signing of a definitive agreement to acquire holistic pet foods leader Halo, Purely for Pets® (Halo®). Halo’s® commitment is to creating exceptional food for pets and its pet nutrition products use OrigiNative™ GAP and MSC-certified proteins that say no to factory farming and offer Superior Digestibility.
Mr. Damian Dalla-Longa, Better Choice Company Chief Executive Officer, said, “Halo® is a well-established, premium brand and falls squarely in line with our goal to build an all-encompassing, global, animal health and wellness consumer product goods company. Over the last three decades, Halo® has built a strong reputation and loyal consumer following, carving out a niche in the industry with high-quality animal products that contain whole food meat and fish and non-GMO ingredients.”
Better Choice Company, Inc. (BTTR), closed Wednesday's trading session at $3.75, up 15.3846%, on 4,984 volume with 25 trades. The average volume for the last 3 months is 18,524 and the stock's 52-week low/high is $1.32599997/$13.2600002.
Concierge Technologies, Inc. (CNCG)
Stock Gumshoe, Real Investment Advice, Trading View, Stockopedia, Stock News Now, Equity Clock, Investor Point, Market Exclusive, Marketbeat, Stockhouse, Wallmine, Market Screener, and Wallet Investor reported previously on Concierge Technologies, Inc. (CNCG), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Concierge Technologies, Inc. is a global holding firm, with operating subsidiaries in financial services, food manufacturing, security systems and beauty products. The Company’s offices and manufacturing operations are in the USA, New Zealand and Canada. Concierge Technologies’ goal is to acquire other diverse companies that are established, profitable, have in-place management teams, sustainable business models and can be purchased for a fair price. OTCQB-listed, Concierge Technologies is based in San Clemente, California.
The Company’s subsidiaries include Brigadier Security Systems, Ltd. (Saskatoon, Saskatchewan); Gourmet Foods, Ltd. (Tauranga, New Zealand); Original Sprout; and USCF (Walnut Creek, California). The Company, through its subsidiaries, produces, packs, and distributes meat pies and related bakery confections to the groceries, gasoline convenience stores, and independent retailers in the U.S., New Zealand, and Canada. Furthermore, Concierge Technologies engages in the provision of security alarm system installation and monitoring services; and wholesale distribution of hair and skin care products under the brand name Original Sprout.
Brigadier Security Systems provides comprehensive security solutions to homes and businesses, government offices, schools and other public buildings throughout the Province of Saskatchewan. Gourmet Foods is a commercial-scale bakery. It produces and distributes iconic meat pies and pastries throughout New Zealand under the brand names Pat's Pantry and Ponsonby Pies.
USCF Investments serves as manager, operator or investment adviser to 13 exchange traded products, structured as limited partnerships or investment trusts that issue shares trading on the NYSE Arca. Original Sprout produces and distributes a complete line of vegan, safe, non-toxic hair and skin care products, including a "reef safe" sun screen.
At the end of September, Concierge Technologies announced financial results for the fiscal year and Q4 ended June 30, 2019. For the year ended June 30, 2019, it reported Revenues of $26.9 million, versus $28.7 million for the previous year. The Company reported Net Income of $261,849, equal to $0.01 per fully diluted share, for fiscal 2019, in comparison to $1.7 million, or $.05 per fully diluted share, for the previous year. Concierge had cash and cash equivalents of $6.5 million at fiscal year-end in addition to $3.8 million in cash investments, essentially no debt, and total assets of $21.3 million.
Concierge Technologies, Inc. (CNCG), closed Wednesday's trading session at $1.19, even for the day, on 40 volume with 1 trade. The average volume for the last 3 months is 657 and the stock's 52-week low/high is $0.654044985/$1.85000002.
Exactus, Inc. (EXDI)
NetworkNewsWire, Zacks, OTC Presswire, Wallet Investor, Penny Stock Tweets, Stockwatch, Investors Hangout, Stockopedia, Market Screener, Stockhouse, InvestorsHub, Proactive Investors, Trading View, and 4-Traders reported beforehand on Exactus, Inc. (EXDI), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Exactus, Inc. is a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products. In addition, it is developing point of care diagnostics. Exactus sells its CBD products direct to consumers via its Hemp Healthy® brand. The Company also sells white label products to third-party resellers. Exactus is based in Delray Beach, Florida and the Company lists on the OTC Markets Group’s OTCQB.
Moreover, Exactus engages in producing industrial hemp from farms in the State of Oregon. Its plan is to extract and manufacture directly through cGMP facilities. Exactus One World is the name of the Exactus farming and production program.
In May of this year, Exactus intensified its efforts to lead the industry in the hemp-derived Cannabidiol (CBD) market with its initial planting of seedlings in roughly 200 prime acres in southwest Oregon on its Exactus One World (EOW) farms. The Company reported the arrival of an independent fairness opinion from Scalar, LLC highlighting EOW’s estimated enterprise value between about $55 million and $74 million. EOW is planting a variety of genetics. It expects to yield thousands of pounds of hemp and top-quality flower per acre.
With the acquisition of Hemp Healthy, the Company’s plan is to introduce and launch additional CBD products in 2019. It states that Hemp Healthy will continue to serve as an information resource and leader in the CBD market place through setting the industry standards on transparency and quality with every product. In addition, the Hemp Healthy platform offers a sales affiliate program for medical professionals and social influencers.
Exactus entered into a Master Product Development and Supply Agreement with Ceed2Med in 2019. Ceed2Med uses cGMP facilities. With this Agreement, Exactus has been allotted a minimum of 50 and up to 300 kilograms per month, and up to 2,500 kilograms per year, of active phyto-cannabinoid (CBD) rich ingredients for resale. Exactus offers tinctures, edibles, capsules, and topical solution products manufactured for use by Ceed2Med. Ceed2Med is a worldwide sourcing and distribution platform for industrial hemp and industrial hemp-derived products.
This past August, Exactus announced the acquisition of Green Goddess Extracts. Green Goddess is a highly regarded Florida contract manufacturer and formulator of hemp and vape products. It manufactures and distributes a premium line of high-quality hemp products sold via distributors and online.
Last month, Exactus announced that its Executive Team returned from an assessment of the farm in Southwest Oregon and reported that the crop is healthy and appears to be on course to produce about 30,000 plus pounds of smokable top flower. This is up from the original estimate of 20,000.
This month, Exactus announced that it launched its e-commerce platform, exactushemp.com. The Company is currently providing its Green Goddess Extracts™ brand of cannabidiol (CBD) products that are available direct to consumer and also wholesalers by way of its platform. This will be followed by a number of additional brands now in its pipeline. Also, yesterday, Exactus announced that it acquired the luxury cosmetic brand LeVor Collection. This is a health, wellness and beauty company in South Florida. LeVor Collection provides unique health and beauty products that go beyond convention, sharing the numerous natural advantages and benefits of the cannabis plant.
Exactus, Inc. (EXDI), closed Wednesday's trading session at $0.78, off by 1.2658%, on 20,539 volume with 13 trades. The average volume for the last 3 months is 42,493 and the stock's 52-week low/high is $0.048/$4.00.
Gran Colombia Gold Corp. (TPRFF)
Micro Small Cap, Investing.com, Mining & Energy, Junior Mining Network, Dividend Investor, Metals News, GuruFocus, Gold Stock Data, Wallet Investor, Morningstar, The Prospector News, Resource World, Wallet Investor, and OTC Markets reported beforehand on Gran Colombia Gold Corp. (TPRFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Gran Colombia Gold Corp. is a mid-tier gold producer listed on the OTC Markets Group’s OTCQX. Its principal emphasis is in Colombia where it is presently the largest underground gold and silver producer with several mines in operation at its Segovia and Marmato Operations. Currently, Gran Colombia is in the midst of an expansion and modernization project at its high grade, production stage Segovia Operations. Gran Colombia Gold has its corporate office in Toronto, Ontario.
The Company’s focus is on the development of the Segovia Operations and Marmato projects to produce strong cash flows in the short, medium and long term. Gran Columbia produces gold from the Segovia Operations, an area of about 9,000 hectares in the Segovia-Remedios mining district of Antioquia. The Segovia Operations include the El Silencio, Providencia, and Sandra K underground mines in the Municipality of Segovia, and the Carla underground mine in the Municipality of Remedios, located approximately 10 km southeast of the Segovia mines.
The Marmato Project contains total estimated resources of around 8 million ounces of gold and close to 38 million ounces of silver situated in the Caldas department in the heart of the Middle Cauca gold district. The Marmato Project has premier infrastructure, being located by the Pan American Highway with access to Medellin to the north and Manizales to the south. It has access to the national electricity grid which runs near the property.
Gran Colombia Gold also has its Zancudo project. The Zancudo project is in the Titiribí mining district of Antioquia. It consists of an historical gold mine, the Independencia Mine, in the Middle Cauca Gold Belt that produced roughly 130,000 ounces of gold with recovered grades of 14.6 g/t Au and 108.4 g/t Ag.
Yesterday, Gran Colombia Gold announced that it completed an updated Mineral Resource estimate for its Marmato Project prepared in accordance with the Canadian Institute of Mining Metallurgy and Petroleum (CIM) Definition Standards incorporated by reference in National Instrument 43-101 (NI 43-101) with an effective date of July 31, 2019. In addition, the Company announced yesterday that SRK Consulting (U.S.), Inc. completed preliminary results of a Preliminary Economic Assessment (PEA) for the Marmato Project, centered on the Zona Baja mining operations, effective July 31, 2019, and is now finalizing the technical report to be filed on SEDAR and Gran Colombia’s website by the end of November 2019.
Serafino Iacono, Executive Chairman of Gran Colombia Gold, commenting on the preliminary results of the Marmato technical study, said, “We are very pleased to have reached the point at which we can see a path forward to significantly expand production from our Marmato Project and, through the recently announced spin out, create value for our shareholders while protecting our capital structure and balance sheet.”
Gran Colombia Gold Corp. (TPRFF), closed Wednesday's trading session at $3.8966, up 2.437%, on 72,931 volume with 216 trades. The average volume for the last 3 months is 46,906 and the stock's 52-week low/high is $1.71949994/$4.4440999.
HIVE Blockchain Technologies Ltd. (HVBTF)
TipRanks, Invest Tribune, Stockwatch, 4-Traders, Market Screener, Micro Small Cap, Blockchain Stocks, FXStreet, Smarter Analyst, Crypto141, Dividend Investor, InvestorsHub, Wallmine, Investors Hangout, YCharts, Trading View, Insider Financial, Stockhouse, and Simply Wall St reported beforehand on HIVE Blockchain Technologies Ltd. (HVBTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
HIVE Blockchain Technologies Ltd. is a company building a bridge from the blockchain sector to traditional capital markets. It is strategically partnered with Genesis Mining Ltd. to build the next generation of blockchain infrastructure. HIVE’s corporate mission is to speed up the development of the blockchain sector via traditional capital markets and create long-term shareholder value. HIVE Blockchain Technologies has its head office in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets’ OTCQX.
HIVE owns state-of-the-art GPU-based digital currency mining facilities in Iceland and Sweden that produce newly minted digital currencies including Ethereum continuously as well as a cloud-based ASIC-based capacity that produces newly minted digital currencies including Bitcoin. HIVE’s deployments provide shareholders with exposure to the operating margins of digital currency mining and an increasing portfolio of crypto-coins.
The Company has an exclusive arrangement with Genesis Mining to operate its data centers under a Master Service Agreement. The data centers will be monitored with Genesis Hive, which is Genesis Mining's proprietary software tool for large-scale mining, to automatically optimize chip temperatures and power consumption for maximal coin production.
Pertaining to the Iceland Cryptocurrency Mining Project, HIVE’s launch transaction involved the acquisition of an initial state-of-the-art blockchain infrastructure facility in Iceland from Genesis Mining. This facility produces mined cryptocurrency around the clock. Assembly of the facility, which uses innovative computing components and infrastructure design, was completed in May of 2017. In Sweden, HIVE's GPU facilities were completed in April of 2018. They are equipped with custom Genesis A2 mining rigs.
HIVE Blockchain Technologies launched the operation of an additional 100 PH of cloud-based ASIC Bitcoin mining on December 1, 2018. This brings its digital currency mining footprint to a total of 24.2 MW of GPU mining and 300 PH of ASIC capacity.
Last week, HIVE Blockchain Technologies announced its results for Q1 ended June 30, 2019. Q1 2020 highlights include generating Income of $9.1 million, with a Gross Mining Margin of $3.6 million from mining of digital currencies. The Company mined 1,331 newly minted Bitcoin during the period. Moreover, it mined roughly 35,000 Ethereum Classic and greater than 3,200 newly minted Ethereum during the period. HIVE earned Net Income of $5.6 million for the period.
For the quarter ended June 30, 2019 , HIVE's Gross Mining Margin was 39 percent. Q1 Income From Digital Currency Mining was produced from an average of 3.8 MW of GPU production capacity, and 300 PH of Cloud Mining capacity, as at June 30, 2019.
HIVE Blockchain Technologies Ltd. (HVBTF), closed Wednesday's trading session at $0.1516, off by 2.1935%, on 127,395 volume with 63 trades. The average volume for the last 3 months is 330,587 and the stock's 52-week low/high is $0.093000002/$0.609000027.
Jaguar Health, Inc. (JAGX)
Infront Analytics, Stock Twits, Stockwatch, Proactive Investors, TradingView, Street Insider, Stockhouse, Alpha Stock News, Super Stock Screener, Market Screener, and Investing.com reported previously on Jaguar Health, Inc. (JAGX), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Jaguar Health, Inc. is a commercial stage pharmaceutical company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Its wholly-owned subsidiary is Napo Pharmaceuticals, Inc. Napo centers on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the worldwide market from plants used traditionally in rainforest areas. Jaguar Health is based in San Francisco, California and the Company lists on the NasdaqGS.
Jaguar Health’s mission is to identify human and animal health market opportunities where it can develop targeted products that leverage its wide-ranging intellectual property (IP) portfolio, deep pipeline, and extensive botanical library. The Company’s emphasis is naturally derived health solutions for humans and animals around the world.
Jaguar Health’s Mytesi® (crofelemer) product is approved by the U.S. FDA (Food and Drug Administration) for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. MYTESI® is not indicated for the treatment of infectious diarrhea.
Jaguar Health announced this past summer that Indena S.p.A., one of the two contract manufacturers of the active pharmaceutical ingredient (API) in crofelemer, successfully developed and implemented an improved crofelemer manufacturing process. This effectively boosts yield and realizes reduced cost through increased manufacturing efficiencies. This is while keeping the same phytochemical profile without compromising product quality, safety, purity and efficacy. Indena, of Milan, Italy, is a leading CDMO provider, with a focus on complex small molecules and natural derivatives.
At the beginning of October, Jaguar Health announced that on September 30, 2019, it filed the Target Animal Safety technical section with the U.S. Food & Drug Administration's Center for Veterinary Medicine (CVM) for the Company’s application for conditional approval of Canalevia™ (crofelemer delayed-release tablets) for chemotherapy-induced diarrhea (CID) in dogs. This technical section is the last of the four major technical sections Jaguar Health is required to file for conditional approval of Canalevia for the proposed CID indication.
Last week, Jaguar Health announced that it engaged Angel Pond Capital, LLC to explore potential licensing agreements and collaborations for Mytesi® in China. Angel Pond has offices in New York and Hangzhou, China. Lisa Conte, Jaguar Health's President and Chief Executive Officer, said, "Jaguar has engaged Angel Pond as an advisor to help facilitate and negotiate the out-license of our Mytesi and crofelemer technology in China, including identifying additional potential strategic partners in China beyond those Jaguar has already engaged in discussions and due diligence.”
Jaguar Health, Inc. (JAGX), closed Wednesday's trading session at $0.725, up 2.3289%, on 462,970 volume with 1,029 trades. The average volume for the last 3 months is 1,103,984 and the stock's 52-week low/high is $0.640999972/$42.7000007.
Williams Industrial Services Group, Inc. (WLMS)
Zacks, TipRanks, OTC Markets, Market Wire News, MarketBeat, Last10k, Market Screener, Simply Wall St, GuruFocus, Nasdaq, TMXmoney, Seeking Alpha, Whale Wisdom, PR Newswire, TradingView, MarketWatch, Morningstar, and Proactive Investors reported earlier on Williams Industrial Services Group, Inc. (WLMS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Williams Industrial Services Group, Inc. is a construction and maintenance services company listed on the OTC Markets’ OTCQX. It provides an extensive range of construction, maintenance and modification, and support services to customers in energy, power and industrial end markets. The Company previously went by the name Global Power Equipment Group, Inc. It changed its name to Williams Industrial Services Group, Inc. in June of 2018. Founded in 1958, the Company has its head office in Tucker, Georgia.
Williams Industrial Services Group provides Plant Services, Specialty Services, and Industrial Services. Regarding Plant Services, the Company is a foremost provider of complete plant maintenance and modifications services, capital construction, and a broad array of specialty and support services to its clients in the power generation, oil and gas, pulp and paper, and other heavy industrial markets. Services include support for ongoing plant operations, regularly scheduled and emergency outages, refueling, shutdowns, turnarounds, and other major maintenance projects needed by its clients.
Williams Industrial Services Group is a multi-industry leader in Specialty Services. The Company has set the standard for protective coatings application, insulation, roofing systems, asbestos and lead abatement and other maintenance specialties in an array of industrial markets.
Pertaining to Industrial Services, Williams’ Industrial Services company provides almost all of the services provided by its Plant and Specialty Services companies - but in open shop labor environments. Work normally performed includes Facility Maintenance, Major Modifications, Outages, Shutdowns and Turnarounds, and New Construction. Main industries served include Water & Wastewater Treatment, Oil & Gas/Petrochemical, Pulp & Paper, and Power Generation.
Recently, Williams Industrial Services Group announced the appointment of Mr. Randall R. Lay as Senior Vice President and Chief Financial Officer effective September 30, 2019. Mr. Lay brings four decades of leadership experience in finance and accounting, information technology (IT), strategic planning, and mergers & acquisitions (M&A) for private and public companies in the specialty chemicals, telecommunications, industrial manufacturing and automotive retail industries.
Most recently, Mr. Lay was Executive Vice President, Chief Financial Officer, Secretary and Treasurer of GEO Specialty Chemicals, Inc., a supplier of specialty chemicals and materials to the coatings, adhesives, medical, water treatment and construction markets, from December 2017 to August 2019, when GEO was acquired by CPS Performance Materials.
Williams Industrial Services Group, Inc. (WLMS), closed Wednesday's trading session at $1.75, up 2.9412%, on 2,000 volume with 4 trades. The average volume for the last 3 months is 6,338 and the stock's 52-week low/high is $1.60000002/$2.6400001.
Blue Eagle Lithium, Inc. (BEAG)
All Penny Stocks, Simply Wall St, Nasdaq, Financial Buzz, Stockhouse, OTC Markets, Last10k, and Market Screener reported earlier on Blue Eagle Lithium, Inc. (BEAG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
A lithium exploration company, Blue Eagle Lithium, Inc. engages in identifying, evaluating, and developing early-stage lithium exploration opportunities in North America. The design of the Company’s growth strategy is to maximize shareholder value through a singular emphasis on lithium exploration and development in secure and stable North American regions. OTCQB-listed, Blue Eagle Lithium has its corporate headquarters in Henderson, Nevada.
The Company’s initial property is in Railroad Valley, Nevada, a highly prospective green-fields Petro-Lithium brine target region that features numerous similarities to the nearby Clayton Valley and which Blue Eagle Lithium believes warrants an extensive exploration program. It has a 100 percent Working Interest (WI) in 276 placer claims in Railroad Valley.
The Company’s Railroad Property warrants surface and shallow drilling evaluation for possible surface-mineable lithium-rich units based on different sources of geological data. The main exploration target within the Railroad Property would be more recent playa sediments, mostly within 2,000 feet (610 meters) of the valley’s surface. Railroad Valley is an isolated sedimentary basin. It exhibits all the important attributes of a large commercial petro-lithium discovery.
Recently, Blue Eagle Lithium announced that it has engaged Rangefront Geological to begin an extended soil sampling program covering its original 4,000 acre land position in Railroad Valley and its recently acquired acreage, the latter of which has received only limited evaluations to date. Rangefront Geological is a premier geological contracting and consulting company based locally out of Elko, Nevada. A crew from Rangefront will be mobilized to start work on the properties with the goal to gather up to 250 near surface clay and brine samples.
In addition, Blue Eagle Lithium announced it further extended its land package through the exercise of an option agreement clause. This extends its land holdings by an additional 520 acres (26 Mineral Claims). In total, the land package now held by Blue Eagle Lithium is 5,520 acres (276 claims, approximately 2,223 Hectares).
Blue Eagle Lithium, Inc. (BEAG), closed Wednesday's trading session at $0.25, up 25.00%, on 8,951 volume with 10 trades. The average volume for the last 3 months is 26,081 and the stock's 52-week low/high is $0.009999999/$1.41999995.
INHIBITOR Therapeutics, Inc. (INTI)
Simply Wall St, 4-Traders, Infront Analytics, Morningstar, MarketWatch, InvestorsHub, BUYINS.NET, Stockhouse, Dividend Investor, and Wallet Investor reported earlier on INHIBITOR Therapeutics, Inc. (INTI), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
INHIBITOR Therapeutics, Inc. is a clinical stage biopharmaceutical company headquartered in Tampa, Florida. It discovers, develops, and plans to commercialize front-line therapeutics for patients with cancer. The Company is looking to repurpose the Food and Drug Administration (FDA) approved antifungal pharmaceutical itraconazole as a potential treatment for cancer. INHIBITOR Pharmaceuticals lists on the OTC Markets Group’s OTCQB.
INHIBITOR is the exclusive United States licensee of a patented formulation of itraconazole, called SUBA-Itraconazole. Clinical studies have shown it to have more bioavailability than generic itraconazole. The Hedgehog signaling pathway is a significant regulator of cellular processes in vertebrates. This includes cell differentiation, tissue polarity, as well as cell proliferation.
The Company believes (based on published research) that inhibiting the Hedgehog pathway could delay or possibly prevent the development of certain cancers in humans. Leveraging research undertaken by key investigators in the field, INHIBITOR’s plan is to explore the effectiveness of SUBA-Itraconazole as an anti-cancer agent and to pursue its potential commercialization.
The design of “SUBA technology” (which stands for “Super Bioavailability”) is to improve the bioavailability of orally administered drugs that are poorly soluble. SUBA-Itraconazole is a patented formulation developed by Mayne Pharma. It has improved absorption and substantially reduced variability in comparison to generic itraconazole.
In August of 2018, INHIBITOR Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) confirmed INHIBITOR’s present clinical and regulatory pathway related to the Company’s SUBA™-Itraconazole as a treatment for Basal Cell Carcinoma (BCC) in patients with Basal Cell Carcinoma Nevus Syndrome (BCCNS, or Gorlin Syndrome).
Recently, INHIBITOR Pharmaceuticals announce that it entered into a revised Supply and License Agreement (SLA) with its majority stockholder Mayne Pharma Ventures Pty Ltd (Mayne Pharma), an affiliate of Mayne Pharma Group Limited. With the new SLA, Mayne Pharma will assume control of the regulatory and clinical development program for SUBA®-Itraconazole for the treatment of basal cell carcinoma nevus syndrome (SUBA-Itraconazole BCCNS) in expectation of conducting a worldwide Phase 3 pivotal clinical trial based on results attained in the Phase 2(b) trial conducted by INHIBITOR in the United States. Mayne Pharma will immediately assume responsibility for all future SUBA-Itraconazole BCCNS-related expenses.
INHIBITOR Therapeutics, Inc. (INTI), closed Wednesday's trading session at $0.07345, even for the day, on 75 volume. The average volume for the last 3 months is 3,763 and the stock's 52-week low/high is $0.040150001/$0.280000001.
Bannerman Resources Limited (BNNLF)
Penny Stock Tweets, MarketWatch, Wallmine, Morningstar, Northern Miner, Capital Cube, Wallet Investor, HotStocked, 4-Traders, MoneyHub, Speculating Stocks, Research and Markets, Streetwise Reports, Stockhouse, The Stock Market Watch, Barchart, and Ventureline reported earlier on Bannerman Resources Limited (BNNLF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Bannerman Resources Limited is an exploration and development company with a 95 percent interest in the Etango Uranium Project in Namibia. The Company is a member of the Namibian Uranium Association, Namibian Chamber of Mines and the Australia-Africa Minerals % Energy Group (AAMEG). Bannerman Resources has its corporate office in Perth, Western Australia. The Etango project office is in Swakopmund, Namibia. Bannerman lists on the OTC Markets.
The Etango Uranium Project is one of the world’s largest undeveloped uranium projects. It is one of the few uranium projects worldwide with a completed Definitive Feasibility Study (DFS) and environmental permitting. A two year pilot supports the DFS. The Etango Uranium Project will be a top 10 producer upon development.
The Etango license area is approximately 500 square kms. The Project is considered by Bannerman Resources to be a low technical and environmental risk project, with conventional open pit mining and sulphuric acid heap leaching at 20 million tonnes per annum.
The Etango Uranium Project is situated on the flat Namib Desert sands, roughly 38 kilometers (by road) east of the coastal town of Swakopmund. The Project is well located for external infrastructure requirements.
Based on the DFS, production is anticipated to be 7-9 million pounds U3O8 per annum for the first five years and 6-8 million pounds U3O8 per annum subsequently. Etango will have a minimum mine life of 16 years with considerable expansion potential via the conversion of existing Inferred Resource and the deposit being open at depth and along strike.
A heap leach demonstration plant has technically de-risked the Etango Uranium Project. Etango has first-rate leaching dynamics, low acid consumption, as well as no impurities or clays. There exist large satellite deposits close by. In addition, Etango is the largest uranium development project or mine not presently owned by an international uranium major or state owned entity (SOE).
Bannerman Resources Limited (BNNLF), closed Wednesday's trading session at $0.0349, up 34.2308%, on 62,500 volume with 3 trades. The average volume for the last 3 months is 120,660 and the stock's 52-week low/high is $0.025/$0.0449.
CleanSpark, Inc. (CLSK)
Stockrow, Financial Content, WalletInvestor, Investor Place, Penny Stock Tweets, Investors Hangout, Street Insider, OTC Markets, InvestorsHub, Stockhouse, The Street, Market Exclusive, 4-Traders, Stock News Now, and Momentus News reported earlier on CleanSpark, Inc. (CLSK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
CleanSpark, Inc. is a microgrid company with advanced engineering, software and controls for innovative distributed energy resource management systems. The Company provides advanced energy software and control technology, which enables a plug-and-play enterprise solution to modern energy challenges. The Company previously went by the name Stratean, Inc. It changed its corporate name to CleanSpark, Inc. in November 2016. CleanSpark’s shares trade on the OTC Markets’ OTCQB.
CleanSpark’s services consist of intelligent solar monitoring solutions, microgrid design and engineering, project development consulting services, system installation and consulting, and turn-key microgrid implementation services. Additionally, the Company combines its microgrid services with a leading-edge and patented stratified downdraft gasifier.
CleanSpark’s products include DNAPOWERPLAN™, Turnkey Microgrid Development Services, and mPULSE GRID MANAGEMENT™. Its PowerPlan shows owners, tenants and stakeholders how to use energy generation, storage and advanced automation to achieve 25, 50 or even 100 percent grid independence.
Regarding Turnkey Microgrid Development Services, CleanSpark develops, constructs, installs and maintains income producing nano and microgrids. CleanSpark helps customers make money through developing their own energy assets.
Concerning mPULSE GRID MANAGEMENT™, the Company’s mPulse software and controls package collects, archives, as well as analyzes data 24/7. This provides real-time control and reporting. It ensures that a customer’s projects are performing according to the DNA PowerPlan. Through advanced monitoring, predictive analytics and professional maintenance, CleanSpark ensures optimal performance of a customer’s microgrid and maximum revenue.
CleanSpark executed an agreement for an $18.3 million 'Zero Net Energy' Microgrid with an S&P 500 Member Real Estate Investment Trust (REIT). This agreement calls for CleanSpark to provide engineering, design, and consultation services and follow-on construction work to install a Microgrid designed by its engineering team and employing its mVSO software in creating the system design. The completed system will be operated by CleanSpark's patented mPulse enterprise controller. Project completion is planned for mid-2019.
CleanSpark is nearing construction completion on its $900,000 contract with Bethel-Webcor JV to install a 'turn-key advanced microgrid system' at the U.S. Marine Corps Base Camp Pendleton. This contract has been in direct support of the United States Department of Navy's communication information system (CIS) operations complex. CleanSpark has performed as a sub-contractor to the JV for the design and construction of the microgrid spanning numerous facilities with inter-connectivity at the U.S. Marine Corps Base Camp Pendleton project P-1132.
CleanSpark, Inc. (CLSK), closed Wednesday's trading session at $0.5587, up 24.1832%, on 750,693 volume with 271 trades. The average volume for the last 3 months is 85,709 and the stock's 52-week low/high is $0.414999991/$7.9499998.
AEON Global Health Corp. (AGHC)
Amigo Bulls, Stock Target Advisor, Stockopedia, Investors Hangout, Penny Stock Hub, Stockwatch, Simply Wall St, Zacks, Stockhouse, InvestorsHub, YCharts, TradingView, The Street, Stockflare, and Dividend Investor reported on AEON Global Health Corp. (AGHC), and today we report on the Company, here at the QualityStocks Daily Newsletter.
AEON Global Health Corp., together with its subsidiaries, provides a variety of clinical laboratory testing services in the United States. The Company provides diagnostic services in Cancer Genomics, Toxicology, Pharmacogenomics, as well as Health Technology Applications. AEON formerly went by the name Authentidate Holding Corp. It changed its name to AEON Global Health Corp. in January 2018. OTCQB-listed, AEON Global Health has its corporate office in Gainesville, Georgia.
The Company is the fastest growing clinical lab and healthcare services organization in the United States. It is first in healthcare technology research and development (R&D) where its proprietary methodologies provide expedited and highly accurate urine and oral fluid (saliva) test results. AEON’s chief business focus is providing a “personalized medicine” approach to laboratory testing services. This is to provide customers with actionable medical information.
AEON is an innovator in the genomic testing area. The Company has an extensive menu of genetic tests and a pipeline of additional molecular-based tests in development. It provides post contract customer support services. The design of AEON’s Telehealth Solutions is to improve outcomes and reduce hospital readmission through helping clinicians closely monitor patients with chronic illnesses. These include CHF, COPD and Diabetes.
Concerning Toxicology Testing, AEON Global Health provides accurate and fast quantitative testing of drug metabolite levels in urine and oral ﬂuids. The Company’s testing covers more than 80 analytes and metabolites. Its HPLC-tandem mass spectrometry can analyze wider molecular weight and polarity ranges of analytes, providing better selectivity and sensitivity.
AEON Clinical Labs services include Cancer Genomics, Pharmacogenomics, Toxicology, and Women’s Health. Health Technologies services include Inscrybe®. This is a secure and simple interface. Inscrybe® enables physicians, nurses, hospital staff, and external care facilities or health insurers to send, receive, sign, and track healthcare records, supporting documents, patient discharge orders and referrals or lab results and images on the web or via electronic fax instead of transferring paper.
In May 2018, AEON Global Health announced it earned The Joint Commission’s Gold Seal of Approval® for Laboratory Services Accreditation by demonstrating continuous compliance with its performance standards. The Gold Seal of Approval is a symbol of quality, which reflects an organization’s commitment to providing safe and effective patient care.
AEON Global Health underwent a thorough onsite survey earlier in 2018. During the review, a Joint Commission expert surveyor evaluated compliance with laboratory standards related to a number of areas. This included document and process control, healthcare-associated conditions, risk reduction, as well as staff qualifications and competency. Additionally, the surveyor conducted onsite observations and interviews.
AEON Global Health Corp. (AGHC), closed Wednesday's trading session at $0.115, up 43.75%, on 12,336 volume with 6 trades. The average volume for the last 3 months is 7,006 and the stock's 52-week low/high is $0.079999998/$0.814999997.
Anfield Energy, Inc. (ANLDF)
Streetwise Reports, InvestorsHub, MarketWatch, OTC Markets, Stockhouse, and Investing News reported on Anfield Energy, Inc. (ANLDF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Anfield Energy, Inc. engages in the acquisition, exploration, development, and production of mineral properties in the United States. The Company is a uranium development and near-term production enterprise. Anfield is concentrating on two production centers - the Irigary ISR (in-situ recovery) processing plant in Wyoming and the Shootaring Canyon Mill in Arizona/Utah. Anfield Energy is based in Vancouver, British Columbia.
The Company’s commitment is to becoming a top-tier energy-related fuels supplier through creating value via sustainable, efficient growth in its energy metals assets. Its uranium assets comprise conventional mining claims and State leases in southeastern Utah, Colorado, and Arizona. Anfield’s conventional uranium assets include the Velvet-Wood Project, the Frank M Uranium Project, and the Findlay Tank breccia pipe.
The Company’s key asset is the Shootaring Canyon Mill in Garfield County, Utah. The Shootaring Canyon Mill is strategically located within one of the historically most prolific uranium production areas in the United States. Furthermore, it is one of only three licensed uranium mills in the United States. In 2017, Anfield Energy continued advancing the Shootaring Canyon Uranium Mill license towards operational status with the Utah Division of Waste Management and Radiation Control.
Concerning the Irigaray ISR Processing Plant (Resin Processing Agreement), the Company’s ISR mining projects are in the Black Hills, Powder River Basin, Great Divide Basin, and Laramie Basin, Shirley Basin, and Wind River Basin regions in Wyoming. These consist of 2,667 federal mining claims, 56 Wyoming State leases, and 15 private leases acquired from Uranium One in September 2016.
Anfield Energy’s Clarkson Hill project consists of roughly 500 acres of the mineral holdings of the Company. The Clarkson Hill project includes 25 unpatented mining lode claims situated about 20 air miles southwest of Casper, Wyoming.
Anfield will evaluate the feasibility of adding a vanadium processing facility to its Shootaring Canyon uranium mill. This reflects its intention to capitalize on potential opportunities as vanadium continues to become an even-more relevant commodity in the energy sector.
Anfield Energy announced in December of 2017 a conceptual vanadium exploration target at its Velvet-Wood Mine in Utah. BRS Engineering completed an Exploration Target report, entitled "Velvet-Wood Vanadium Exploration Target, National Instrument 43-101, Utah, U.S.A.", with effective date of December 11, 2017 that provides a vanadium exploration target of between 6.3Mlbs and 9.7Mlbs at a grade of between 0.4 percent V2O5 and 0.61 percent V2O5.
Anfield engaged BRS Engineering to update the Company’s NI 43-101 Preliminary Economic Assessment (PEA) related to the Velvet-Wood Mine to include a vanadium milling circuit as part of a production scenario.
This past April, Anfield Energy announced the acquisition of an extensive exploration database of mining projects centered chiefly on uranium and vanadium properties in the Western U.S. The new database, together with the Company’s already considerable uranium database, constitutes one of the largest depositories of uranium exploration data in the Western U.S.
Also in April, Anfield Energy announced that it identified vanadium exploration targets in its recently-acquired exploration database of mining projects in the Western U.S. The targets are in Colorado and Utah. They are considered complementary to the Company’s Utah-based Shootaring Canyon mill as Anfield Energy could include a vanadium processing circuit on this asset. Additionally, these vanadium projects could serve as a potential extended vanadium project pipeline beyond the Velvet-Wood uranium/vanadium project.
Anfield Energy, Inc. (ANLDF), closed Wednesday's trading session at $0.0962, up 22.7041%, on 40,903 volume with 11 trades. The average volume for the last 3 months is 26,687 and the stock's 52-week low/high is $0.075000002/$0.272513985.
KinerjaPay Corp. (KPAY)
OTC Markets, InvestorsHub, MarketWatch, TradingView, Stockhouse, Marketbeat, and Barchart reported on KinerjaPay Corp. (KPAY), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Established in 2010, KinerjaPay Corp. focuses on operating a digital payment and e-commerce platform. The Company, through its wholly-owned subsidiary, PT Kinerja Pay Indonesia, enables consumers to "pay, play, and buy" via its secure website and mobile applications. KinerjaPay’s intention is to establish the Company as a leader in Indonesia's digital economy, with a specific emphasis on the middle- and low-income markets. KinerjaPay is based in Indonesia.
A digital payment and ecommerce platform, KinjerPay’s services are available through its mobile applications, and on its website at www.kinerjapay.com. The KinerjaPay platform provides a secure payment solution. In addition, it provides a developing virtual marketplace where participants can buy and sell products and services.
In May 2016, KinerjaPay entered into a partnership with Bitcoin Indonesia. This makes KinerjaPay the first e-commerce portal in Indonesia authorized to accept and transact Bitcoin across its platform. This enables account holders to convert the virtual currency to Indonesian Rupiah to pay their bills, transfer money, or make purchases in the Company's ecommerce market.
KinerjaPay offers several in-app services that cater to mobile users. These in-app services include an eWallet, social engagement, and digital entertainment related applications. Additionally, the Company is pursuing other e-commerce verticals. These include travel, fashion, gaming, and productivity applications.
Moreover, KinerjaPay has created a number of unique features designed to engage users. This includes an interactive gamification component that permits users to play and earn rewards while enjoying the benefits of shopping online. The Company is also providing users the convenience of making online payments of their utility bills, phone top-ups/data plans, insurance premiums, automobile loan instalments, and many other applications.
KinerjaPay plans to expand its digital ecommerce platform with the launch of KinerjaGames. It entered a long-term License Agreement with Ace Legends Pte. Ltd. (ACE). ACE is a Singapore-based game developer.
With this Agreement, in exchange for a $100,000 investment, KinerjaPay will become the exclusive, worldwide Game Publisher License for ACE games. The Company will also host all the games now published by ACE on its own KinerjaGames platform.
This past October, KinerjaPay announced its partnership with Uber Technologies, Inc. Uber is the worldwide smartphone-enabled 'Ride-Hailing' service.
With this partnership, Uber will grant KinerjaPay users an exclusive promotion code for first-time users, valid for four rides. Users can at first redeem the Uber/KinerjaPay promotion code by creating a new account on the Company's eCommerce platform or meeting a certain spending threshold with KinerjaPay's proprietary KinerjaMall service. User/clients can subsequently redeem their unique code directly in their KinerjaPay smartphone app to use the Uber service.
Recently, KinerjaPay announced that it has chosen Blockchain Industries, Inc. and Fintech Global Consultants to transition to a token payment platform. Blockchain Industries, in partnership with Fintech Global Consultants, will be guiding KinerjaPay in its transition from an electronic payment platform to a token payment platform.
KinerjaPay’s plan is to raise up to US $5 million from its imminent ICO (initial coin offerings). The ICO will be offered to institutional or private investors in the form of KCOIN, KinerjaPay's own proprietary virtual currency. With the ICO, KCOIN will be used as KinerjaPay's cryptocurrency on one of the largest cryptocurrency exchanges in Asia.
KinerjaPay Corp. (KPAY), closed Wednesday's trading session at $0.1059, up 37.5325%, on 2,369,195 volume with 154 trades. The average volume for the last 3 months is 880,032 and the stock's 52-week low/high is $0.07/$0.949899971.
The QualityStocks Company Corner
- InsuraGuest Inc.
- Nightfood Holdings, Inc. (OTCQB: NGTF)
- Earth Science Tech, Inc. (ETST)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- SinglePoint, Inc. (SING)
- VPR Brands, LP (VPRB)
- Dama Financial
- ChineseInvestors.com (CIIX)
- Neutra Corp. (OTCQB: NTRR)
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
- Endonovo Therapeutics Inc. (ENDV)
- ORHub Inc. (ORHB)
- MustGrow Biologics Corp. (CSE: MGRO)
- Marijuana Company of America (OTCQB: MCOA)
The QualityStocks Daily Newsletter would like to spotlight InsuraGuest Inc..
InsuraGuest Inc., a SaaS (Software-as-a-Service) company, recently signed a letter of intent (“LOI”) that broadens its InsurTech platform and insurance products from the United States to Europe and the United Kingdom. An article discussing the company reads, “The coverage, unlike travelers insurance, is a specialized policy that provides a first line of defense for both the hotel or vacation-rental property and the travelers during their stays, with a potential of up to 40,000 different properties, and is purchased by the hotel property and then included with each guest’s folio charges for the stay. To view the full article, visit http://nnw.fm/4i5wS.
InsuraGuest Inc. is a SaaS (Software-as-a-Service) company utilizing its proprietary flagship InsurTech software platform to provide specialized insurance products to end users in the business-to-business (B2B) and business-to-consumer (B2C) markets. The company’s first focus is on the B2B hotels and vacation rentals sectors, where its API integrates with the clients’ property management systems to offer guests a specialized guest protection policy. The platform and policy combination “InsurTech” product helps transfer the exposure to liability away from the client/property while guests benefit from potential accident and loss coverage during their stay.
InsuraGuest’s platform is currently capable of integrating with approximately 70 different hotel and vacation rental property management systems, giving it access to roughly 40,000 properties worldwide.
The company continues to pursue expansion opportunities and recently signed a Letter of Intent with a master general agent in the United Kingdom and Europe to distribute its platform and products to hotel and vacation rental markets in those regions, as well as plans to expand to Asia in 2020.
Protecting Guests, Enhancing Customer Experience
InsuraGuest is the first line of defense for both the property and the guest.
InsuraGuest is purchased by the hotel or vacation rental “property,” which offers the policy to each registered guest and its occupants for an additional fee. The specialized policy affords coverage for theft of personal property while in the hotel, as well as accidental medical expense and accidental death and dismemberment, up to the policy limits of $2,500 to $50,000.
The U.S. hotel industry generated more than $218 billion in annual revenues in 2018, an increase of $10 billion from the previous year, according to STR’s 2019 HOST Almanac. The European market is more than double the size of the U.S. market. According to Oxford Economics, there were 6.4 billion nights stayed in the world, with 2.6 billion hotel nights in Asia, 2.8 billion nights stayed in Europe, and 1.1 billion nights in the United States. Additionally, $100 billion was spent on vacation rentals in the United State alone, where there are approximately 4.5 million second homes are being managed by a third-party rental company.
With distribution in Europe and the United States, InsuraGuest’s demographics combined will total 3.9 billion nights stayed, and will more than double its vacation rental opportunities.
Within this burgeoning, high-demand industry is risk of liability to guest injury. For example, gym injuries are among the top five most common hotel accidents. Without proper hedges in place, the property may be liable in a personal injury claim or lawsuit.
Though the potential for accidents, slip and falls and mishaps can be widespread, it can be covered under the InsuraGuest Specialized Guest Protection Policy to provide guests a worry-free and enjoyable stay that potentially increases loyalty for the property.
- Targeting hotels and vacation rentals, a multi-billion-dollar industry
- Providing the first line of defense in case of accident, loss or death
- Expanding distribution reach with footing in European hotel and vacation rental markets
- Expansion into Asia by 2020
Douglas Anderson, Chairman & Chief Executive Officer
Douglas Anderson has been a businessman in the real estate industry for nearly 30 years. His business expertise includes master planning and development implementation for larger-scale resorts, business parks and commercial developments across the USA and two provinces in Canada. His business endeavors include the founding of the 7th larger private equity fund in America focusing on multifamily and senior care (ROC Fund/Bridge IPG Fund). He serves as chairman/founder of a golf and winter sports ski holding company with operations in four major east coast markets and British Columbia, Canada.
Anderson earned a BS undergraduate degree in Consumer Studies with an emphasis in Architecture as an undergraduate at the University of Utah. He subsequently earned his Master’s in Business Administration. He also attended a three-year OPM Program a postgraduate business education at Harvard Business School in Boston. Anderson is an avid skier and outdoor enthusiast.
Charles James Cayias, President & Director
Charles James Cayias is also the president and owner of Charles James Cayias Insurance Inc. He is a third-generation insurance professional whose creativity and artistic vision have enabled him to establish a full-service agency combined with the personal service each client deserves. His outstanding people skills, honesty, integrity and fairness are evident by his loyal and growing clientele, the majority of which are referrals who become long-time customers and friends.
Cayias began his insurance career in the early 1970s and has been licensed since 1977. He is licensed in all 50 states and specializes in niche programs. He has extensive expertise in all aspects of the insurance industry including commercial insurance, employee benefits, workers’ compensation, professional liability, risk management and bonding.
Christopher J. Panos Vice President & Director
Christopher J. Panos is a highly competitive sales professional with over 15 years of territory manager sales experience and an award-winning record of achievements. He is exceptionally well organized with a proven work history that demonstrates self-discipline, superb communication skills, and the initiative to achieve both personal and corporate goals. Panos is successful in building relationships with a large network of industry professionals in order to grow and maintain new and existing business, exceed new sales objectives and provide in-depth product training to authorized dealers and sales personnel.
Alexander Walker III ESQ, Corporate Counsel & Director
Alexander Walker III ESQ has served as director of the company since September of 2018. He also has served as counsel to the company since July of 2018. Walker is an attorney and has been a member of the Utah Bar Association since 1987 and a member of the Nevada State Bar since 2003. His practice has involved general business litigation, in both federal and state courts, and transactional work, including securities offerings and registration, corporate formation and periodic reporting compliance. Walker has provided legal services to emerging businesses throughout his carrier and at times has served as an officer and board member as well as legal counsel public companies. His duties as legal counsel for a public company engaged in the business of ownership and operation of coal-producing properties in the western United States included oversight of corporate-related legal matters including securities reporting, corporate compliance, federal and state mining regulation, and employment law oversight. He also has served as the chair of the Mining Committee of the Energy, Natural Resources and Environmental Law Section of the Utah State Bar, a member of the board of directors of the South East Utah Energy Producers Association, the co-chair of the board of the Western Energy Training Center, a board member of the Utah Supreme Court Committee to Review the ABA Recommendations Regarding the Office of Professional Conduct, and a board member of the University of Utah Crimson Club.
Roger Bloss, Corporate Consultant & Board Advisor
Roger Bloss joined InsuraGuest in August of 2019 to advise the company and its board on hotel transactions, contributing his knowledge from more than 40 years in the hospitality industry. Bloss previously served in executive positions with several major hotel franchise companies and in 1996 founded Vantage Hospitality Group hotel brands. Under his leadership, Vantage became a Top 10 global hotel company and made the Inc. 500/5000 list of Americas’ fastest-growing private companies for eight straight years. Bloss was named Lodging Magazine’s “Innovator of the Year” in 2006 and 2010, and in 2009 earned a spot on HSMAI’s “Top 25 Extraordinary Minds in Sales and Marketing.” Bloss joined Red Lion Hotels Corporation (RLHC) in September 2016 in conjunction with the acquisition of Vantage.
- InsuraGuest Inc. Increases Reach to Include Europe through Landmark LOI
- InsuraGuest Extends the Reach of its Hospitality Stay Insurance to UK and Europe
- InsuraGuest Sign LOI to Sell its Product in the United Kingdom and the European Union
Nightfood Holdings, Inc. (OTCQB: NGTF)
Nightfood, Inc. (OTCQB: NGTF), the start-up ice cream company addressing America’s $50 billion-dollar annual night snacking spend, announced that Nightfood ice cream has begun appearing in hotel pantry freezers and college campus stores through a recently secured, but previously unannounced, distribution partnership.
Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.
Nightfood Ice Cream
Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.
Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.
With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.
Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.
More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.
Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.
Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.
Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.
Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.
MJ Munchies, Inc.
MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.
Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.
Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.
Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.
CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.
The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.
Nightfood Holdings, Inc. (NGTF), closed Wednesday's trading session at $0.2673, up 0.867925%, on 104,062 volume with 31 trades. The average volume for the last 3 months is 147,266 and the stock's 52-week low/high is $0.160099998/$0.920000016.
- Nightfood Ice Cream Secures Initial Hotel Placements Through National Distribution Partner; J.D. Power Research Suggests Opportunity
- Nightfood Announces Distribution in Harris Teeter Supermarkets, Adding Over 250 Stores Throughout the Southeast and Mid-Atlantic Regions
- Nightfood Holdings Inc. (NGTF) Reports Record Quarterly Revenues, Data Indicating Steadily Increasing Same Store Sales
Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. (ETST) was featured today in a publication from HempWireNews, examining how famers in West Virginia are complaining that their hemp crop is undergoing stricter testing than in other states. This stringent testing of THC is putting them at a disadvantage as it costs them huge profits in an industry that is multiplying rapidly.
Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.
Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:
- Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
- Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
- KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.
In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.
The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.
Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.
Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.
The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.
Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.
Earth Science Tech, Inc. (ETST), closed Wednesday's trading session at $0.359, up 2.5714%, on 21,983 volume with 8 trades. The average volume for the last 3 months is 44,003 and the stock's 52-week low/high is $0.300000011/$1.64999997.
- West Virginia Hemp Farmers Unhappy With THC Testing Protocol
- Earth Science Tech Inc. (ETST) Targets Emergent Biotechnology Cannabis Sector
- Earth Science Tech Inc. (ETST) Seeing Revenue Growth, Focusing on Supplying High Quality Hemp Oil
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis-branded product company with the top two best-selling cannabis products in California according to BDS Analytics, is moving into the growing Nevada market (http://cnw.fm/Hp6zE). The company made the move by releasing its infused-gummies product line, which includes the two best-selling cannabis products in California across all categories, into the Silver State.
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Wednesday's trading session at $2.263, off by 1.5059%, on 36,495 volume with 70 trades. The average volume for the last 3 months is 36,160 and the stock's 52-week low/high is $2.17000007/$6.00810003.
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Launches Top-Selling Edibles into Thriving Nevada Adult-Use Cannabis Market
- Plus Products Inc. Presenting at the Benzinga Cannabis Capital Conference in Chicago
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Partners with John Legend, Casper Sleep for Nationwide Launch of CBD-Infused Gummies
SinglePoint, Inc. (SING)
SinglePoint Inc. (OTCQB: SING) CEO Greg Lambrecht was featured in a recent MoneyTV interview, reporting live from the recent National Association of Convenience Stores (NAC) event in Georgia. He noted that SING was the sole exhibitor of hemp cigarettes at the show and spoke optimistically about the product’s commercial potential. SING exhibited its Pure American Hemp Cigarette line to retail owners representing approximately 2,500 stores, selling multiple cases during the show and ordering additional products to meet demand (http://cnw.fm/S2vPg).
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed Wednesday's trading session at $0.01062, up 0.188679%, on 1,197,221 volume with 54 trades. The average volume for the last 3 months is 2,761,366 and the stock's 52-week low/high is $0.009999999/$0.035999998.
- SinglePoint Inc. (SING) Sole Exhibitor of Desirable Hemp Cigarettes at NAC Event, Direct Solar Subsidiary Heating Up Competition in Energy Sector
- Green Light Documentary Predicts CBD Products Will Be Common Like Vitamin Pills
- SinglePoint, Inc. (SING) CEO Reflects on Successful NACS Trade Show on MoneyTV with Donald Baillargeon
VPR Brands, LP (VPRB)
VPR Brands (OTCQB: VPRB), a multivertical, tiered, technology holding company, continues to focus on building first-rate brands in the nicotine and cannabis marketplaces. To view the full article, visit http://cnw.fm/XVh2u
Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.
VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:
- GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit www.cbdgoldline.com.
- HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit www.vapehoneystick.com.
- Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
- Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
- Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
- GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit www.goldlinehemp.com for more information about GoldLine Hemp-only products.
- Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.
CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.
Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.
VPR Brands, LP (VPRB), closed Wednesday's trading session at $0.0395, even for the day, on 57,800 volume with 8 trades. The average volume for the last 3 months is 138,026 and the stock's 52-week low/high is $0.033799998/$0.119999997.
- VPR Brands LP (VPRB) CEO Purchases Significant Personal Shares in Company
- VPR Brands LP (VPRB) Shifting Focus to Rising Star of CBD
- Supply Shortages Force Hemp Seed Processor to Leave Vermont
The QualityStocks Daily Newsletter would like to spotlight Dama Financial.
Although more than 30 states have legalized cannabis use in some form, the majority of businesses in the field are having a hard time gaining access to banking services, leading to the emergence of specialized ancillary services to fill this gap. Dama Financial, a San Francisco-based private company, is one of these service providers, aiming to provide secure online and mobile-friendly banking services to cannabis-related businesses through its bank partners. Dama administers the provision of such solutions as an agent of its partnering financial institutions.
Dama Financial, through its bank partners, provides cannabis-related businesses (CRBs) access to transparent, sustainable banking and payment solutions. Using innovative technology, data and artificial intelligence, Dama exceeds the compliance and regulatory requirements for servicing CRBs, bringing legitimacy to the rapidly growing cannabis industry. Dama’s comprehensive and compliant financial framework offers CRBs the option to maintain cashless operations, reducing their exposure to security risks while improving their business efficiencies and operational focus.
As successful fintech entrepreneurs, Dama’s founders have a proven track record of building companies that have removed the barriers that exclude unbanked categories from accessing the fundamental financial solutions necessary to thrive. During the past three years, Dama’s leadership team has turned its focus to addressing the challenges burdening the cannabis industry – the unbanked category of our time.
On behalf of its bank partners, Dama offers access to:
- Schedule recurring or ad-hoc appointments for secure cash pick-ups and delivery via armored courier
- Monitor activity in real time via desktop or mobile or be notified of transaction alerts via email or text
- Send payments via electronic ACH, wire-transfer or check to approved payees
- Receive electronic funds from approved partners
- Transfer money quickly between Dama-managed accounts
- Schedule secure cash pick-ups and delivery via armored courier
- Monitor activity in real time via desktop or mobile or be notified of transaction alerts via email or text
- Send electronic tax payments to approved tax authorities
- Monitor account activity 24/7 with online and mobile access
- No minimum balance or account fees
- Accept electronic retail payments using the secure PayMyWaySM mobile application
- Customers can fund the app using a linked bank account or debit card at checkout with any PayMyWay merchant
- Funds settle to the merchant’s PayMyWay Merchant account
- Integrates seamlessly with any point-of-sale system
All Dama clients enjoy:
- FDIC insurance on deposits of up to $250,000 per account
- Dedicated Relationship Manager for account-related inquiries
Dama Financial is an agent of its partnering financial institutions and licensed money transmitters. Customers’ funds will be deposited into a custodial account maintained for the benefit of account holders at one or more FDIC-insured institutions. Fees, terms and conditions apply to depositing funds into and using an Account. Account Terms and Conditions and Fee Schedule are available upon registration to access the online application.
- Dama Financial Provides Access to Transparent Banking Services for Cannabis Industry
- Dama Financial is “One to Watch”
- Dama Financial and Helix TCS (HLIX) Partner to Bring Legal Cannabis Industry Financial Solutions Through Market-Leading BiotrackTHC® Software
ChineseInvestors.com (CIIX) was featured today in a publication from CBDWire, examining how, every decade or two, there are medical discoveries made that thoroughly shake up the entire pharmaceutical industry. Drugs such as penicillin, insulin, and thorazin not only changed the scope of how severe medical conditions could be treated, but they were instrumental in helping thousands, if not millions of people, live more comfortable and healthy lives.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
ChineseInvestors.com (CIIX), closed Wednesday's trading session at $0.2585, off by 0.576923%, on 36,646 volume with 10 trades. The average volume for the last 3 months is 42,409 and the stock's 52-week low/high is $0.25/$1.02999997.
- University of Pennsylvania to Study CBD Use in Dogs
- ChineseInvestors.com Inc. (CIIX) Penetrates Asian Markets via Popular Shopping Platform
- ChineseInvestors.com Inc. (CIIX) Takes Aim at National Hemp-Derived CBD Market Forecasted to Reach $7 Billion by 2023
Neutra Corp. (OTCQB: NTRR)
Early-stage research and development company Neutra Corp. (OTCQB: NTRR) together with its subsidiary VIVIS Corp. (www.VivisCorp.com) today announced release of its new CBD-based, menthol-infused sports cream. To view the full press release, visit http://cnw.fm/xNhe3. Also today, the company was featured in the 420 with CNW by CannabisNewsWire.
Neutra Corp. (OTCQB: NTRR) is an early-stage research and development company bringing modern healthy living solutions to a multi-billion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture – one where consumers are demanding access to products that promote health and stave off potential health dangers.
Neutra is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Hemp-based CBD consumer products generated sales of up to $390 million in 2018 with projections pointing to a $3 billion market by 2022, according to the Hemp Business Journal.
Neutra’s new broadened scope, which includes the commercialization of newer, more effective products, aims to capitalize on this worldwide boom. Our company is seeking new and exciting opportunities that can accelerate Neutra’s mission to bring these products to a wider demographic. Our work reflects a renewed dedication to supporting a better body, environment and life for people around the globe.
- VIVIS – Neutra continues to expand its market presence in the rapidly growing hemp-derived CBD market and recently acquired VIVIS, an emerging retail brand of hemp-based health and nutritional products. VIVIS’ hemp-derived CBD products are third-party certified as contaminant-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With VIVIS as the new retail face of Neutra, the company is expecting greater interest in its expanding portfolio of branded products moving to market.
- J3 Holdings – The signing of a letter of intent to acquire J3 Holdings includes the company’s land and warehouse, as well as a license to cultivate hemp and refine it into usable forms. Neutra has concentrated its early efforts developing business networks and on developing hemp-based CBD products, including supplements and creams. The latest move will enable the company to grow its own hemp supply, giving it more control over the quality of its ingredients.
- Surface to Air Solutions is the North American distributor of a patent-pending, water-based solution known as Purteq, a green technology that works similar to photosynthesis.
- ZeroBlast uses a durable, non-toxic, anti-microbial solution to eliminate all contaminates and kill germs on contact for a period of up to 90 days.
Neutra president and CEO Sydney Jim provides strong executive leadership, a network of business contacts and experience implementing solid corporate strategy. Jim has a proven track record of adding value for public company shareholders. He founded Global Visionary Investments where operational support is provided to seven different companies and their subsidiaries. Jim was also the CEO of First Titan Energy, a microcap public company where he was responsible for restructuring the corporate structure, deal sourcing, and leading the company in mergers and acquisitions.
Dr. Scott Cherry is the company’s sports performance medical advisor. He is an energetic physician executive with a passionate focus on health, performance and prevention. Dr. Cherry received emergency medical technician training in the U.S. Navy, a bachelor’s degree in chemistry from Florida State University, medical degree from Nova Southeastern University, and a master’s degree of public health from Uniformed Services University F. Edward Herbert School of Medicine. Dr. Cherry has honed his skills in a variety of medical and executive positions spanning the U.S. Army and Navy, several Fortune 500 corporations, and major health care facilities over the past 20 years.
Neutra Corp. (OTCQB: NTRR), closed Wednesday's trading session at $0.0009, off by 18.1818%, on 134,195,838 volume with 211 trades. The average volume for the last 3 months is 28,696,457 and the stock's 52-week low/high is $0.0006/$0.0898.
- Neutra Corp.’s (NTRR) New Sports Cream Hits Shelves as CBD Products Reach New Heights of Popularity and Sales
- 420 with CNW – Group Campaigns for Congressional Action on Pesticide-Free Marijuana
- Why the World of Fashion Should Turn to Hemp
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was featured today in the 420 with CNW by CannabisNewsWire. Last Tuesday, Beyond Pesticides, a nonprofit organization said that a lack of federal regulations on pesticides used on marijuana plants is putting marijuana consumers at risk. Beyond Pesticides are advising their supporters to send letters to lawmakers urging them to hold hearings and investigations on the illicit use of unapproved pesticides in the legal markets to prevent toxic pesticide contamination. They are urging the state to advise the farmers to adopt an organic system of planting the cannabis crop.
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Wednesday's trading session at $3.44, off by 2.8249%, on 1,612,407 volume with 5,344 trades. The average volume for the last 3 months is 1,269,803 and the stock's 52-week low/high is $2.71000003/$8.43999958.
- 420 with CNW – Group Campaigns for Congressional Action on Pesticide-Free Marijuana
- Cannabis 2.0: Canada Set to Legalize CBD Topicals and Beverages October 17, 2019
- Why the World of Fashion Should Turn to Hemp
Endonovo Therapeutics Inc. (ENDV)
Endonovo Therapeutics Inc. (ENDV) develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, non-invasive medical devices are designed to deliver the company’s proprietary, patent protected Electroceutical™ Therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (“CNS”) disorders.
In accord with its mission to transform the field of medicine through innovation, Endonovo’s bioelectric Electroceutical™ devices harness bioelectricity to restore key electrochemical processes that initiate anti-inflammatory processes and growth factors in the body necessary for healing to rapidly occur. Endonovo’s current portfolio of commercial-stage devices address chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke.
SofPulse® Electroceutical ™ Therapy is an easy-to-place, non-invasive device that delivers pulsed electromagnetic frequencies to enhance post-surgical recovery. Used as a stand-alone therapy or integrated into any treatment protocol, SofPulse®’s?targeted?pulsed electromagnetic field?(tPEMF)?transmits gentle pulses to the tissue causing a positive biological effect to help reduce swelling and accelerate the body’s natural recovery process. The low levels of electromagnetic fields are completely safe and are 1000 times lower than those emitted by a mobile phone.?
Because SofPulse® lessens the pain of post-surgical recovery, the patient requires far less prescription medications, thereby minimizing or eliminating the adverse side effects of narcotics and anti-inflammatory medication. Studies have shown a greater than 2.2-fold reduction in narcotic use over the first 48 hours post-procedure. Patients with less pain and medication may move around sooner, which further stimulates the body’s natural response to healing.
Endonovo’s Electroceutical™ Therapy is cleared by the U.S. Federal Drug Administration (“FDA”) for the palliative treatment of pain and post-surgical edema (swelling) and is CE-marked in the European Economic Area (“EEA”) for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. The Centers for Medicare and Medicaid Services (“CMS”) has also certified Electroceutical™ Therapy for the treatment of chronic wounds.
Alan Collier, Chairman and CEO
Alan Collier has more than 25 years of experience in corporate finance, IP development, telecommunications and technology, with a concentration in healthcare and technology over the past five years. Collier has served as CEO and director of IP Resources International Inc., where he was instrumental in developing a platform the for the licensing and acquisition of life science and technology companies. He has held numerous board and executive positions throughout his career in the telecommunications, technology, specialty finance, corporate finance and healthcare industries. Collier has previously held FINRA Series 7, 79, 63 and 24 licenses.
Michael Scott Mann, President
Michael Scott Mann has over 30 years of experience in merger and acquisitions and operational management. In 2008, Mann acquired the assets of Hanover Asset Management, now Endonovo Therapeutics Inc., and led the company to become listed on the OTCBB in 2012. He was the founder, president and CEO of Frankfurt-listed U.S. Debt Settlement Inc. (USDS), where he implemented a growth by acquisition strategy.?
Don Calabria, Chief Operating Officer
Don Calabria has over 20 years of leadership and experience in national business operations to emerging growth companies, mergers and acquisitions, finance and business development. Calabria holds an MBA from the Graziadio School of Business and Management at Pepperdine University and a bachelor’s degree from Arizona State University.
Nevena Zubcevik, Chief Medical Officer
Nevena Zubcevik, D.O., MSPT, ATC, on July 1, 2019, will lead Endonovo’s medical and clinical strategy, including the development and regulatory matters and new business development. Zubcevik, a licensed physician and educator, has more than 24 years of experience in the medical field and was an attending physician at Harvard Medical School/Partners Healthcare in the physical medicine and rehabilitation department.
Steven Ford, Vice President of Marketing
Steven Ford has 25 years of experience in the field of medical devices, including experience in sales management, product management, product development, business development and research & development at companies such as Baxter, CR Bard, Ethicon, Allergan, Mallinckrodt Pharmaceuticals and Alphatec Spine. Throughout Ford’s career, he has led and participated on over 75 product development teams and has launched over 50 medical devices globally. Ford is an innovative problem solver and has many patents in the areas of hemostasis, sealing and tissue reconstruction. Most recently, Steve was the U.S. vice president of marketing for Biom’up where he was a co-lead on the high-profile successful launch of their surgical hemostat HEMOBLAST Bellows. Steve holds a bachelor’s degree in marketing from California State University.
David Clark, Vice President of Sales
David Clark has extensive surgical device commercial experience which includes 25 years in the surgical device industry with leading companies including Medtronic and Baxter Healthcare. Most recently, Clark was the U.S. executive vice president of sales for Biom’up where he was a co-lead in the high-profile successful launch of their surgical hemostat HEMOBLAST. As part of the launch, he built and led the U.S. sales team which included over 200 in-direct sales representatives and direct commercial leadership. During his 15 years with Baxter, the BioSurgery Division grew from a small revenue business into a major market player in the advanced hemostasis space with products such as FloSeal and Tisseel. Clark has a bachelor’s degree in economics from Rutgers University.
Roc Alan McCarthy, Scientific Advisory Board Member
Roc Alan McCarthy, D.O, will help Endonovo continue to advance its clinical pipeline and contribute to the strategic and clinical development oversight of the company. McCarthy is a urologist in North Carolina, currently serving as the robotic surgeon and chairman of the robotics committee at the New Hanover Regional Medical Center.
Endonovo Therapeutics Inc. (ENDV), closed Wednesday's trading session at $0.01, off by 4.3062%, on 1,929,953 volume with 48 trades. The average volume for the last 3 months is 4,459,549 and the stock's 52-week low/high is $0.006/$0.049499999.
- Endonovo Therapeutics Inc. (ENDV) Appoints Recognized Medical Professional and Business Visionary Dr. William Li as Strategic Advisor to the CEO
- Endonovo Therapeutics Inc. (ENDV) Receives Glowing Video Review on Revolutionary Medical Device
- Endonovo Therapeutics Inc. (ENDV) Developing Solutions to Meet Major Therapeutic Needs
ORHub Inc. (ORHB)
ORHub Inc. (ORHB) is a growth-stage data analytics company on a mission to optimize the business of surgery through lean process improvement. As a Microsoft Silver Partner, ORHub leverages the Azure cloud to help customers unlock the power of data captured in the operating room by surfacing key business indicators into a curated set of dynamic dashboards.
ORHub’s Surgical Spotlight® is a cloud-based analytics tool that helps administrators, nurse leaders and surgeons make improved business decisions for the operating room. By taking data feeds from the facility’s Operating Room Information System, ORHub produces a functional and elegant dashboard that allows users to easily identify opportunities for improvement.
These capabilities allow providers to harness data, identify millions of dollars in opportunities, and get leaders back to their primary focus of improving care, increasing patient access and reducing costs. A first-of-kind team building tool brings all stakeholders together with regular and accessible information. ORHub specializes in business intelligence for the operating room, built by professionals with experience in the operating room.
Surgical Spotlight video featuring renowned cardiac surgeon and ORHub Chief Executive Officer Dr. Robert (“Bobby”) Lazzara
ORHub is proud to partner with top tier facilities and organizations, including:
- Hoag Orthopedic Institute & Hoag Memorial Hospital in the Providence network
- Baptist Health, Jacksonville
- Alvarado Hospital Medical Center in the Prime network
- Orthopedic Institute Surgery Center in the SMP network
- Anderson Regional Medical Center
ORHub has attended and presented at several events in 2019, also gaining approval to present Surgical Spotlight® at nursing forums and offer 1.2 contact hours toward Continuing Education Units (CEU) from Terri Goodman, RN, PhD, & Associates, an approved provider by the California Board of Registered Nursing (provider number CEP 16550).
The U.S. surgical market continues to grow, with over 5,500 hospitals and 6,100 ambulatory surgery centers (ASCs) performing over 50 million medical procedures annually. According to MarketsandMarkets, the global health care analytics market will approach $50 billion by 2024 with a five-year Compound Annual Growth Rate (“CAGR”) of 28.3% from 2019.
Chief Executive Officer Dr. Robert “Bobby” Lazzara is a distinguished cardiac surgeon, a medical media expert, and founder of Medical News Minute. He performed the first worldwide webcast of open-heart surgery in August 1998 through the Virtual Operating Room and is a Smithsonian Laureate for his pioneering work utilizing the internet and information technology as a health care educational tool. Dr. Lazzara has been a member of advisory boards and a consultant to major corporations and medical device companies.
Chief Financial Officer Barney Monte has more than 20 years of global investment banking and capital markets experience. He has worked with numerous growth stage companies.
ORHub Inc. (ORHB), closed Wednesday's trading session at $0.0375, even for the day, on 120,000 volume with 8 trades. The average volume for the last 3 months is 37,080 and the stock's 52-week low/high is $0.020999999/$0.479999989.
- ORHub, Inc. Settles Litigation with Former Chief Financial Officer
- Renowned Cardiac Surgeon and Medical News Minute Founder, Dr. Robert Lazzara, Joins ORHub Team as Chief Medical Officer
- ORHub, Inc. (ORHB) Secures Contract with Anderson Regional Medical Center
MustGrow Biologics Corp. (CSE: MGRO)
The QualityStocks Daily Newsletter would like to spotlight MustGrow Biologics Corp..
MustGrow Biologics (CSE: MGRO) is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.
Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients (http://nnw.fm/Qkz21). For the past 50 years, nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical?formulations.
MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://nnw.fm/3HGuT), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.
MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.
MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.
Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:
- 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
- 55 percent tomato crop yield increase
- 95 percent control of Pythium root rot in lettuce fields
- 70 percent reduction in Verticillium root severity in cucumbers
- Market Opportunity
MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers.?MustGrow’s?potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis.?
Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated?$9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.??
MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.
President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries.? Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.
Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.
COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.
Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis?(TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.
Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.
CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.
MustGrow Biologics Corp. (CSE: MGRO), closed Wednesday's trading session at $0.31, even for the day, on 14,500 volume with 5 trades. The average volume for the last 3 months is 41,385 and the stock's 52-week low/high is $0.25/$0.699999988.
- MustGrow Outlines Portfolio of Natural Bio-Pesticides and Bio-Fertility Products
- 420 with CNW – Benefits of Marijuana to People with Traumatic Brain Injury
- MustGrow Obtains Exclusive Rights of Streptomyces Bio-Fungicide Product Used to Treat Powdery Mildew in Cannabis Production
Marijuana Company of America Inc. (MCOA)
Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOA), closed Wednesday's trading session at $0.253, up 15.00%, on 659,345 volume with 268 trades. The average volume for the last 3 months is 198,463 and the stock's 52-week low/high is $0.023/$2.10599994.
- 420 with CNW – Nearly a Thousand Businesses Sign Letter Asking Congress to Deschedule Marijuana
- Global CBD Prices Reduce as US Supply Shakes the Market
- 420 with CNW – Benefits of Marijuana to People with Traumatic Brain Injury
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) B2 Social Media Network Surpasses 3.9M Connections in Q2 2019
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Opens Learning Center Featuring Augmented Reality Games, Educational Content
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) Featured in Broadcast Discussing California’s Cannabis Industry
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) View from the C-Suite: Narbé Alexandrian, President & Chief Executive Officer, Canopy Rivers Inc., tells his company's story. Filmed on September 24, 2019
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) 420 with CNW – Marijuana Will be Legalized this Month, Says Mexican Senate Leader
- ChineseInvestors.com (CIIX) Penetrates Asian Markets via Popular Shopping Platform
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Names New CFO; Announces Private Placement, Equity Issuances
- CloudCommerce (OTCQB: CLWD) Employs Behavioral-Science Approach to Identify Custom Audiences
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Earth Science Tech, Inc. (ETST) Targets Emergent Biotechnology Cannabis Sector
- Endonovo Therapeutics (OTCQB: ENDV) Appoints Recognized Medical Professional and Business Visionary Dr. William Li as Strategic Advisor to the CEO
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Enters Strategic Agreement with Leading Chinese Infrared Camera Manufacturer
- Genprex, Inc. (NASDAQ: GNPX) Announces Plans to Present at Inaugural MicroCap Rodeo Investor Conference
- Geyser Brands Inc. (TSX.V: GYSR) University of Wyoming Releases Hemp Publication
- GP Solutions (GWPD) Trading to Recommence October 17, 2019
- Grapefruit Boulevard Investments Inc. (IGNG) Key Requirements for Starting a Successful CBD Brand
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Key Requirements for Starting a Successful CBD Brand
- Green Hygienics Holdings Inc. (GRYN) Hemp Pollen Researchers Get USDA Grant
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- HTC Extraction Systems (TSX.V: HTC) Creates Proprietary, Ethanol-Based Distillation System
- INmune Bio, Inc. (NASDAQ: INMB) to Present at Advances in Immuno-Oncology USA Congress and at World Immunotherapy Congress in October
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Reports Milestone Q2 Revenues, Completes Transformational Acquisitions
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Advances Innovation Research Through Agreement with Altria
- Marijuana Company of America Inc. (MCOA) 420 with CNW – Nearly a Thousand Businesses Sign Letter Asking Congress to Deschedule Marijuana
- MustGrow Biologics Corp (CSE: MGRO) Outlines Portfolio of Natural Bio-Pesticides and Bio-Fertility Products
- Neutra Corp. (OTCQB: NTRR) Why the World of Fashion Should Turn to Hemp
- Nightfood, Inc. (OTCQB: NGTF) Announces Distribution in Harris Teeter Supermarkets, Adding Over 250 Stores Throughout the Southeast and Mid-Atlantic Regions
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Why the World of Fashion Should Turn to Hemp
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Opportunity Research Report Issued by Goldman Small Cap Research
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Ability to Employ Clean Oil Recovery Technology
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Partners with John Legend, Casper Sleep for Nationwide Launch of CBD-Infused Gummies
- Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Takes Part in Groundbreaking Genomes Project
- Pressure BioSciences Inc. (PBIO) Proprietary PCT Platform Demonstrates Ability to Discover Cancer Biomarkers in Independent Research
- Quest Patent Research Corp. (QPRC) Committed to Protecting Financial Data System, Takes Apple to Court on Patent Infringement Charges
- Sharing Services Global Corporation (SHRG) Subsidiary’s Innovative Wellness Products Offer Customers a D.O.S.E. of Happines
- SinglePoint, Inc. (SING) Green Light Documentary Predicts CBD Products Will Be Common Like Vitamin Pills
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Leading Taxi Technology Distributor Increases Purchase Order to Over $850,000
- Spectrum Global Solutions, Inc. (SGSI) Set to Capitalize on Rising TELCO CAPEX
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) 420 with CNW – ACLU Sues County in Pennsylvania over Medical Marijuana
- SRAX Inc. (NASDAQ: SRAX) Partners with ZAP, One of the Largest Loyalty Programs in the Philippines, to Integrate Point-of-Sale Data with BIGtoken
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) CEO to Participate at September 17 Battery Next Summit in Boulder, CO
- Sugarmade, Inc. (SGMD) 420 with CNW – 5 Things to Discuss about Medical Marijuana with Your Doctor
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) 420 with CNW – ACLU Sues County in Pennsylvania over Medical Marijuana
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) The Psilocybin Mushroom Story Could be the Next Big Investment Boom
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Green Light Documentary Predicts CBD Products Will Be Common Like Vitamin Pills
- Trxade Group Inc. (TRXD) Empowers Small, Independent Pharmacies
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Reaffirms Timing of First Harvest at Kimmetts and Additional 2020 Cultivation Plans
- VPR Brands, LP (VPRB) Shifting Focus to Rising Star of CBD
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Advancing Toward Global Expansion Goal
- Willow Biosciences Inc. (CSE: WLLW) New Study Finds Florida Residents Among the Heaviest of CBD Users
- Xalles Holdings Inc. (XALL) Targets Growing Global Account-Reconciliation Software Market
- Youngevity International, Inc. (NASDAQ: YGYI) Signs Letter of Intent with BeneYOU, LLC
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.